This site is intended only for healthcare professionals in the Philippines.

Search

Menu

Close

Sign InLog OutOur medicinesTherapy areasExplore contentExplore contentEventsMaterialsVideosLet’s connectLet's ConnectContact usAsk a questionPfizer medical information
Menü
Schließen
KontaktanfrageService & RessourcenService & RessourcenBestellshop
ABRYSVO® Zur Produktseite MaternaleLoading Zur Produktseite Ältere Erwachsene Loading FachinformationLoading

Adverse events should be reported. Reporting forms and information can be found at https://primaryreporting.who-umc.org/PH
Adverse events should also be reported to Pfizer - Report Adverse Events

PfizerPro AccountPfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign inRegister

This site is intended only for healthcare professionals in the Philippines. If you are a member of the public wishing to access information on a specific medicine, please visit www.pfizer.com.ph

 

Copyright © 2023 Pfizer Limited. All rights reserved.

PP-A1G-PHL-0060 | March 2025
You are now leaving PfizerPro
​​​​​​​
​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
business which it has provided or reviewed.

PP-PFE-GBR-3859. November 2021
​​​​​​​
For Healthcare Professionals in the Philippines*

These pages are not intended for patients or for members of the general public. The web pages contain promotional content.

I confirm that I am a licensed healthcare professional practicing in the Philippines.

If you select ‘No’, you will be redirected to www.pfizer.com.ph

For more details on the definition of who is a Registered Healthcare Professional, please visit:
LERIS | Professional Regulation Commission

Accessed March 2025

 

No Yes